The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 8, 2004, Pages 1017-1021

  Amirzargar, Ali Aakbar ^a   Yalda, A ^b   Hajabolbaghi, M ^b   Khosravi, F ^a   Jabbari, H ^b   Rezaei, N ^c   Niknam, M H ^a   Ansari, B ^a   Moradi, B ^a   Nikbin, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic susceptibility; Human leukocyte antigen; Iran; Tuberculosis

Indexed keywords

GENOMIC DNA; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA TYPING; HUMAN; IRAN; LUNG TUBERCULOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM SMEAR; THORAX RADIOGRAPHY;

AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IRAN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 3543071015     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. 1991. Bull World Health Organ 2001; 79: 71-75.
2. Murray C J, Lopez A D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
3. Centers for Disease Control. Leads from the MMWR. A strategic plan for the elimination of tuberculosis in the United States. JAMA 1989; 261: 2941-2492.
4. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 2003; 4: 4-11.
5. Moss D J, Khanna R. Major histocompatibility complex: from genes to function. Immunol Today 1999; 20: 165-167.
6. Schluger N W, Rom N W. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998; 157: 679-691.
7. Nowell W R, Trowsdale J, Beck S. MHCDB: database of the human MHC (release 2). Immunogenetics 1996; 45: 6-8.
8. Singh S P N, Mehra N K, Dingley H B, Pande J B, Vaidya M C. Human leukocyte antigen (HLA) linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
9. Khomenko A G, Litvinov V I, Chukanovo V P, Pospelov L E. Tuberculosis in patients with various HLA phenotypes. Tubercle 1990; 71: 187-192.
10. Selvaraj P, Reetha A M, Uma H, et al. Influence of HLA-DR and -DO phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tubercle Lung Dis 1996; 77: 369-373.
11. Hawkins B R, Higgins D A, Chan S L, Lowrie D B, Mitchison D A, Girling D J. HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis 1988; 138: 1616-1621.
12. Hafez M, el-Salab S, el-Schennaway F, Bassiony M R. HLA-antigens and tuberculosis in the Egyptian population. Tubercle 1985; 66: 35-40.
13. Hwang C H, Khan S, Ende N, Mangura B T, Reichman L B, Chou J. The HLA-A, -B, and -DR phenotypes and tuberculosis. Am Rev Respir Dis 1985; 132: 382-385.
14. Cox R A, Downs M, Neimes R E, Ognibene A J, Yamashita T S, Ellner J J. Immunogenetic analysis of human tuberculosis. J Infect Dis 1988; 158: 1302-1308.
15. Rajalingam R, Mehra N K, Jain R C, Myneedu V P, Pande J N. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis 1996; 173: 669-676.
16. Ravikumar M, Dheenadhayalan V, Rajaram K, et al. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tubercle Lung Dis 1999; 79: 309-317.
17. Teran-Escandon D, Teran-Ortiz L, Camarena-Olvera A, et al. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 1999; 115: 428-433.
18. Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
19. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
20. Haldane J B. The estimation and significance of the logarithm of a ratio of frequency. Ann Hum Genet 1956; 20: 309-311.
21. Bothamley G H, Gibbs J H, Beck J S, et al. Delayed hypersensitivity and HLA in smear-positive pulmonary tuberculosis. Int Arch Allergy Immunol 1995; 106: 38-45.
22. Singal D P, D'Souza M, Sood S K. Polymorphism of HLA-DR2, DQw1 haplotypes in Asian Indians. Tissue Antigens 1990; 36: 164-170.
23. Wang J, Song C, Wang S. Association of HLA-DRB1 genes with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 2001; 24: 302-305.
24. Selvaraj P, Sriram U, Mathan Kurian S, Reetha A M, Narayanan P R. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinb) 2001; 81: 335-341.
25. Goldfeld A E, Delgado J C, Thim S, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.